MedTrace Logo

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

NCT05768269 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 375

Last updated 2025-06-25

No results posted yet for this study

Summary

This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is an observational study, and the elements of the study design allow for important follow-up for safety, survival, and the continued evaluation of any late adverse events (AEs) that may appear after treatment with such cellular products. Additionally, collection of persistence data from participants will support the identification of any long-term risks or late AEs that may be causally related to treatment with such cellular products.

Conditions

  • Hematological Malignancy
  • Solid Tumor Malignancy

Interventions

OTHER

No Intervention

As this is a non-interventional rollover, long-term safety follow-up study, no intervention will be administered.

Sponsors & Collaborators

  • Century Therapeutics, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-29
Primary Completion
2040-03-31
Completion
2040-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05768269 on ClinicalTrials.gov